Adult Kawasaki disease: report of two cases and literature review
- PMID: 15942913
- DOI: 10.1016/j.semarthrit.2005.01.012
Adult Kawasaki disease: report of two cases and literature review
Abstract
Objectives: To describe 2 cases of adult Kawasaki Disease (KD) and to review the medical literature to better define the epidemiological, clinical, laboratory, histopathological, cardiovascular, and therapeutic aspects of adult KD compared with pediatric KD.
Methods: Report of 2 cases, and review of the literature using a Medline search from 1967 to June 2003.
Results: Including our 2 cases, there are 57 reports of adult KD, 74% among patients aged 18 to 30 years. Nine cases of KD associated with human immunodeficiency virus (HIV) infection were described, suggesting that an immunocompromised state may predispose to this syndrome. The incidence of specific diagnostic criteria was roughly similar in adults and in children. However, cheilitis, meningitis, and thrombocytosis were observed in a larger percentage of children, while arthralgia, adenopathy, and liver function abnormality were more common in adults. Although adult KD often was diagnosed after the acute phase, when a significant beneficial effect from gammaglobulin infusion could not be expected, this treatment did appear to shorten the course of the disease. Coronary aneurysms were less frequent in adults than in children. Prognosis was more favorable in adults, with less cardiovascular complications and no deaths.
Conclusions: Adult KD is a rare condition, which may go unrecognized. Other known disease processes with similar clinical presentations such as hypersensitivity drug reaction and toxic shock syndrome must be ruled out. For adult KD, exclusion criteria such as absence of hypotension, visceral impairment, staphylococcal infection, and any drug able to induce a drug hypersensitivity reaction are suggestive of the diagnosis, in the presence of the inclusion criteria, rash, conjunctival effusion, oropharynx changes, extremity changes, or adenopathy.
Similar articles
-
Kawasaki-like syndromes in HIV-infected adults.J Infect. 2007 Dec;55(6):488-94. doi: 10.1016/j.jinf.2007.09.005. Epub 2007 Oct 22. J Infect. 2007. PMID: 17953991 Review.
-
Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience.J Paediatr Child Health. 2005 Sep-Oct;41(9-10):495-9. doi: 10.1111/j.1440-1754.2005.00690.x. J Paediatr Child Health. 2005. PMID: 16150066
-
Infections and Kawasaki disease: implications for coronary artery outcome.Pediatrics. 2005 Dec;116(6):e760-6. doi: 10.1542/peds.2005-0559. Pediatrics. 2005. PMID: 16322132
-
Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.J Paediatr Child Health. 2004 Sep-Oct;40(9-10):524-9. doi: 10.1111/j.1440-1754.2004.00456.x. J Paediatr Child Health. 2004. PMID: 15367145
-
[Kawasaki disease: what you need to know].Arch Pediatr. 2012 Nov;19(11):1264-8. doi: 10.1016/j.arcped.2012.07.005. Epub 2012 Aug 24. Arch Pediatr. 2012. PMID: 22921712 Review. French.
Cited by
-
Past Endemic Izumi Fever or Yersinia pseudotuberculosis Infection Reappears Sporadically.Intern Med. 2024 May 1;63(9):1317-1322. doi: 10.2169/internalmedicine.1161-22. Epub 2023 Oct 13. Intern Med. 2024. PMID: 37839888 Free PMC article.
-
Two Distinct Cases of Adult-onset Kawasaki Disease.Intern Med. 2022 Dec 1;61(23):3525-3529. doi: 10.2169/internalmedicine.9044-21. Epub 2022 Apr 23. Intern Med. 2022. PMID: 35466164 Free PMC article.
-
Multisystem inflammatory syndrome with erythema multiforme-like rash in an adult after mRNA COVID-19 vaccination.Ann Dermatol Venereol. 2022 Sep;149(3):211-213. doi: 10.1016/j.annder.2022.02.001. Epub 2022 Feb 11. Ann Dermatol Venereol. 2022. PMID: 35248401 Free PMC article. No abstract available.
-
Resolution of coronary arteritis following tuberculosis treatment.J Clin Tuberc Other Mycobact Dis. 2022 Jan 19;26:100295. doi: 10.1016/j.jctube.2021.100295. eCollection 2022 Feb. J Clin Tuberc Other Mycobact Dis. 2022. PMID: 35079638 Free PMC article.
-
Atypical Kawasaki Disease after COVID-19 Vaccination: A New Form of Adverse Event Following Immunization.Vaccines (Basel). 2022 Jan 16;10(1):126. doi: 10.3390/vaccines10010126. Vaccines (Basel). 2022. PMID: 35062787 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
